0001157523-22-000044.txt : 20220111 0001157523-22-000044.hdr.sgml : 20220111 20220111064520 ACCESSION NUMBER: 0001157523-22-000044 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220111 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERKINELMER INC CENTRAL INDEX KEY: 0000031791 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042052042 STATE OF INCORPORATION: MA FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05075 FILM NUMBER: 22522714 BUSINESS ADDRESS: STREET 1: 940 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-663-5791 MAIL ADDRESS: STREET 1: 940 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: EG&G INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: EDGERTON GERMESHAUSEN & GRIER INC DATE OF NAME CHANGE: 19670626 8-K 1 a52560227.htm PERKINELMER, INC. 8-K
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K
 
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): January 11, 2022

 

PerkinElmer, Inc.
(Exact Name of Registrant as Specified in its Charter)

 
 
Massachusetts
001-05075
04-2052042
(State or Other Jurisdiction
of Incorporation or Organization)
(Commission
File Number)
(IRS Employer
Identification No.)
 
940 Winter Street, Waltham, Massachusetts
02451
(Address of Principal Executive Offices)
(Zip Code)
 
Registrant’s telephone number, including area code: (781) 663-6900
 
Not applicable
(Former Name or Former Address, if Changed Since Last Report)

 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
   Trading Symbol(s)
   Name of exchange on which registered
Common stock, $1 par value per share
  
PKI
  
The New York Stock Exchange
1.875% Notes due 2026
  
PKI 21A
  
The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company   ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02.
Results of Operations and Financial Condition

 
On January 11, 2022, PerkinElmer, Inc. issued a press release regarding the fiscal quarter ended January 2, 2022.  The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits

(d)        Exhibits

EXHIBIT INDEX

Exhibit No.
Description
 
 
 
  
104
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).

* This exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed.



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
 
PERKINELMER, INC.
Date: January 11, 2022
By: /s/ Joel S. Goldberg
Joel S. Goldberg
Senior Vice President, Administration, General Counsel and Secretary

EX-99.1 2 a52560227ex991.htm EXHIBIT 99.1
Exhibit 99.1

PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022

  • Fourth quarter 2021 revenue and earnings per share to exceed prior guidance
  • Non-COVID organic growth in fourth quarter 2021 of approximately 10%
  • Fourth quarter 2021 COVID product and services related revenue of approximately $320 million

WALTHAM, Mass.--(BUSINESS WIRE)--January 11, 2022--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth for the fourth quarter of 2021 of approximately -1% and -12%, respectively, versus the same period a year ago. Adjusted earnings per share from continuing operations is expected to be at least $2.40 for the fourth quarter ended January 2, 2022.

The stronger than expected results in the fourth quarter of 2021 were driven by upside in both non-COVID and COVID product lines relative to management’s previous guidance. Non-COVID organic revenue growth in the fourth quarter is expected to be approximately 10% which would result in full year 2021 non-COVID organic revenue growth of approximately 16%. The Company also expects to report fourth quarter 2021 COVID related revenues of approximately $320 million. This will bring the full year 2021 contribution from COVID related products and services to over $1.5 billion.

For the full year 2021, the Company now expects total revenues of approximately $5.0 billion, with approximately $2.9 billion coming from its Diagnostics segment and approximately $2.1 billion coming from its Discovery and Analytical Solutions segment.

PerkinElmer will release its fourth quarter and full year 2021 financial results after market close on Tuesday, February 1, 2022. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Jamey Mock, senior vice president and chief financial officer, will host the conference call.

To access the call, a live audio webcast of the call will be available via this registration form or on the Investors section of the Company's website at www.perkinelmer.com.

A replay of the webcast will be available beginning at 7:00 p.m. ET, Tuesday, February 1, 2022 through the Investors section of the Company’s website.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities, acquisitions and divestitures. Words such as "believes," "intends," "anticipates," "plans," "expects," “estimates”, "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) the effect of the COVID-19 pandemic on our sales and operations; (3) fluctuations in the global economic and political environments; (4) our failure to introduce new products in a timely manner; (5) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (6) our ability to compete effectively; (7) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (8) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (9) disruptions in the supply of raw materials and supplies; (10) our ability to retain key personnel; (11) significant disruption in our information technology systems, or cybercrime; (12) our ability to realize the full value of our intangible assets; (13) our failure to adequately protect our intellectual property; (14) the loss of any of our licenses or licensed rights; (15) the manufacture and sale of products exposing us to product liability claims; (16) our failure to maintain compliance with applicable government regulations; (17) regulatory changes; (18) our failure to comply with healthcare industry regulations; (19) economic, political and other risks associated with foreign operations; (20) the United Kingdom’s withdrawal from the European Union; (21) our ability to obtain future financing; (22) restrictions in our credit agreements; (23) discontinuation or replacement of LIBOR; (24) significant fluctuations in our stock price; (25) reduction or elimination of dividends on our common stock; and (26) other factors which we describe under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food, and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of more than 16,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available at www.perkinelmer.com.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this announcement also contains non-GAAP financial measures. The reasons we use these measures, reconciliations of organic revenue growth and non-COVID organic revenue growth guidance to the most directly comparable GAAP measures, and other information relating to these measures are included below.

Adjusted earnings per share guidance is also provided on a non-GAAP basis and cannot be reconciled to the closest GAAP measures without unreasonable effort due to the unpredictability of the amounts and timing of events affecting the items the Company excludes from this non-GAAP measure. The timing and amounts of such events and items could be material to the Company’s results prepared in accordance with GAAP.

PerkinElmer, Inc. and Subsidiaries

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)





 


PKI



Three Months Ended




January 2, 2022


Organic revenue growth and non-COVID organic revenue growth:

Projected


Reported revenue growth
approximately

-1%


Less: effect of foreign exchange rates

-1%


Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses

11%


Organic revenue growth
approximately

-12%


Less: revenue growth from COVID products

-22%


Non-COVID organic revenue growth (2)
approximately

10%






 




 




 


PKI



Twelve Months Ended




January 2, 2022


Organic revenue growth and non-COVID organic revenue growth:

Projected


Reported revenue growth
approximately

33%


Less: effect of foreign exchange rates

1%


Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses

8%


Organic revenue growth
approximately

24%


Less: revenue growth from COVID products

8%


Non-COVID organic revenue growth (2)
approximately

16%






 
(1) amounts may not sum due to rounding







 
(2) excludes revenue from COVID-related products and services in both periods



Explanation of Non-GAAP Financial Measures

We report our financial results in accordance with GAAP. However, management believes that, in order to more fully understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash, non-recurring or other items, which result from facts and circumstances that vary in frequency and impact on continuing operations. Accordingly, we present non-GAAP financial measures as a supplement to the financial measures we present in accordance with GAAP. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by adjusting for certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management's ability to make useful forecasts. Management believes these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.

We use the term “organic revenue” to refer to GAAP revenue, excluding the effect of foreign currency changes and revenue from recent acquisitions and divestitures and including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We use the related term “organic revenue growth” to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year. We use the related term “non-COVID organic revenue growth” to refer to the measure of comparing current period organic revenue excluding revenue from COVID related products and services with the corresponding period of the prior year excluding revenue from COVID related products and services.

We use the term “adjusted earnings per share,” or “adjusted EPS,” to refer to GAAP earnings per share, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding discontinued operations, amortization of intangible assets, debt extinguishment costs, other purchase accounting adjustments, acquisition and divestiture-related expenses, acceleration of executive compensation, significant litigation matters and settlements, significant environmental charges, changes in the value of financial securities, disposition of businesses and assets, net, asset impairments and restructuring and other charges. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate this non-GAAP measure. We also adjust for any tax impact related to the above items and exclude the impact of significant tax events.

Management includes or excludes the effect of each of the items identified below in the applicable non-GAAP financial measure referenced above for the reasons set forth below with respect to that item:

  • Amortization of intangible assets— purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
  • Debt extinguishment costs—we incur costs and income related to the extinguishment of debt; including make-whole payments to debt holders, accelerated amortization of debt fees and discounts, and expense or income from hedges to lock in make whole payments. We exclude the impact of these items from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
  • Revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules— accounting rules require us to account for the fair value of revenue from contracts assumed in connection with our acquisitions. As a result, our GAAP results reflect the fair value of those revenues, which is not the same as the revenue that otherwise would have been recorded by the acquired entity. We include such revenue in our non-GAAP measures because we believe the fair value of such revenue does not accurately reflect the performance of our ongoing operations for the period in which such revenue is recorded.
  • Other purchase accounting adjustments—accounting rules require us to adjust various balance sheet accounts, including inventory, fixed assets and deferred rent balances to fair value at the time of the acquisition. As a result, the expenses for these items in our GAAP results are not the same as what would have been recorded by the acquired entity. Accounting rules also require us to estimate the fair value of contingent consideration at the time of the acquisition, and any subsequent changes to the estimate or payment of the contingent consideration and purchase accounting adjustments are charged to expense or income. We exclude the impact of any changes to contingent consideration from our non-GAAP measures because we believe these expenses or benefits do not accurately reflect the performance of our ongoing operations for the period in which such expenses or benefits are recorded.
  • Acquisition and divestiture-related expenses—we incur legal, due diligence, stay bonuses, incentive awards, stock-based compensation, interest expense, foreign exchange gains and losses, integration expenses and other costs related to acquisitions and divestitures. We exclude these expenses from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
  • Asset impairments—we incur expense related to asset impairments. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred.
  • Acceleration of executive compensation—the announced retirement of a senior executive resulted in an acceleration of compensation expense. We exclude these expenses from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
  • Restructuring and other charges—restructuring and other charges consist of employee severance, other exit costs as well as the cost of terminating certain lease agreements or contracts as well as costs associated with relocating facilities. Management does not believe such costs accurately reflect the performance of our ongoing operations for the period in which such costs are reported.
  • Adjustments for mark-to-market accounting on post-retirement benefits—we exclude adjustments for mark-to-market accounting on post-retirement benefits, and therefore only our projected costs are used to calculate our non-GAAP measures. We exclude these adjustments because they do not represent what we believe our investors consider to be costs of producing our products, investments in technology and production, and costs to support our internal operating structure.
  • Significant litigation matters and settlements—we incur expenses related to significant litigation matters, including the costs to settle or resolve various claims and legal proceedings. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred.
  • Significant environmental charges—we incur expenses related to significant environmental charges. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred.
  • Disposition of businesses and assets, net—we exclude the impact of gains or losses from the disposition of businesses and assets from our adjusted earnings per share. Management does not believe such gains or losses accurately reflect the performance of our ongoing operations for the period in which such gains or losses are reported.
  • Impact of foreign currency changes on the current period— we exclude the impact of foreign currency from these measures by using the prior period’s foreign currency exchange rates for the current period because foreign currency exchange rates are subject to volatility and can obscure underlying trends.
  • Impact of significant tax events—we exclude the impact of significant tax events, such as the Tax Cuts and Jobs Act of 2017. Management does not believe the impact of significant tax events accurately reflects the performance of our ongoing operations for the periods in which the impact of such events was recorded.
  • Changes in value of financial securities—we exclude the impact of changes in the value of financial securities. Management does not believe such gains or losses accurately reflect the performance of our ongoing operations for the period in which such gains or losses are reported.

The tax effect for discontinued operations is calculated based on the authoritative guidance in the Financial Accounting Standards Board’s Accounting Standards Codification 740, Income Taxes. The tax effect for amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, debt extinguishment costs, other costs related to business acquisitions and divestitures, acceleration of executive compensation, significant litigation matters and settlements, significant environmental charges, changes in the fair value of financial securities, adjustments for mark-to-market accounting on post-retirement benefits, disposition of businesses and assets, net, restructuring and other charges, and the revenue from contracts acquired with various acquisitions is calculated based on operational results and applicable jurisdictional law, which contemplates tax rates currently in effect to determine our tax provision. The tax effect for the impact from foreign currency exchange rates on the current period is calculated based on the average rate currently in effect to determine our tax provision.

The non-GAAP financial measures described above are not meant to be considered superior to, or a substitute for, our financial statements prepared in accordance with GAAP. There are material limitations associated with non-GAAP financial measures because they exclude charges that have an effect on our reported results and, therefore, should not be relied upon as the sole financial measures by which to evaluate our financial results. Management compensates and believes that investors should compensate for these limitations by viewing the non-GAAP financial measures in conjunction with the GAAP financial measures. In addition, the non-GAAP financial measures included in this earnings announcement may be different from, and therefore may not be comparable to, similar measures used by other companies.

Each of the non-GAAP financial measures listed above is also used by our management to evaluate our operating performance, communicate our financial results to our Board of Directors, benchmark our results against our historical performance and the performance of our peers, evaluate investment opportunities including acquisitions and discontinued operations, and determine the bonus payments for senior management and employees.

Contacts

Media Relations:
Chet Murray
(781) 663-5728
chet.murray@perkinelmer.com

Investor Relations:
Steve Willoughby
(781) 663-5677
steve.willoughby@perkinelmer.com

EX-101.SCH 3 pki-20220111.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 pki-20220111_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 pki-20220111_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Domain] Common Stock [Member] Class of Stock [Axis] Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name 1.875% Notes due 2026 [Member] EX-101.PRE 6 pki-20220111_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.21.4
Document and Entity Information
Jan. 11, 2022
Entity Listings [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 11, 2022
Entity Registrant Name PerkinElmer, Inc.
Entity Incorporation, State or Country Code MA
Entity File Number 001-05075
Entity Tax Identification Number 04-2052042
Entity Address, Address Line One 940 Winter Street
Entity Address, City or Town Waltham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02451
City Area Code 781
Local Phone Number 663-6900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000031791
Common Stock [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Common stock, $1 par value per share
Trading Symbol PKI
Security Exchange Name NYSE
1.875% Notes due 2026 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.875% Notes due 2026
Trading Symbol PKI 21A
Security Exchange Name NYSE
XML 8 a52560227_htm.xml IDEA: XBRL DOCUMENT 0000031791 2022-01-11 2022-01-11 0000031791 pki:One875NotesDue2026Member 2022-01-11 2022-01-11 0000031791 us-gaap:CommonStockMember 2022-01-11 2022-01-11 false 0000031791 8-K 2022-01-11 PerkinElmer, Inc. MA 001-05075 04-2052042 940 Winter Street Waltham MA 02451 781 663-6900 false false false false Common stock, $1 par value per share PKI NYSE 1.875% Notes due 2026 PKI 21A NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 3 118 1 false 2 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://perkinelmer.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports a52560227.htm a52560227ex991.htm pki-20220111.xsd pki-20220111_def.xml pki-20220111_lab.xml pki-20220111_pre.xml http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a52560227.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "pki-20220111_def.xml" ] }, "inline": { "local": [ "a52560227.htm" ] }, "labelLink": { "local": [ "pki-20220111_lab.xml" ] }, "presentationLink": { "local": [ "pki-20220111_pre.xml" ] }, "schema": { "local": [ "pki-20220111.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" ] } }, "elementCount": 35, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 1, "memberStandard": 1, "nsprefix": "pki", "nsuri": "http://perkinelmer.com/20220111", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "a52560227.htm", "contextRef": "c20220111to20220111", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://perkinelmer.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "a52560227.htm", "contextRef": "c20220111to20220111", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "pki_One875NotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "1.875% Notes due 2026 [Member]" } } }, "localname": "One875NotesDue2026Member", "nsuri": "http://perkinelmer.com/20220111", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://perkinelmer.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001157523-22-000044-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-22-000044-xbrl.zip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end